Scarica l'app Stockscreener
368.10
0.45%
1.66
Dopo l'orario di chiusura:
368.50
0.40
+0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Amgen Inc Borsa (AMGN) Ultime notizie
How Safe Is Amgen's Dividend? - The Motley Fool
Amgen focuses on pipeline and strategy as investors watch earnings trajectory - AD HOC NEWS
Integrated Advisors Network LLC Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Kiley Juergens Wealth Management LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Hodges Capital Management Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc growth story and pipeline outlook - AD HOC NEWS
Amgen Inc. $AMGN Shares Sold by Burney Co. - MarketBeat
AMGN Maintained by Truist Securities -- Price Target Raised to $340 - GuruFocus
Amgen highlights its science-driven pipeline as investors weigh long-term growth - AD HOC NEWS
Amgen stock leans on its pipeline. Investors track a U.S. biotech giant. - AD HOC NEWS
Amgen highlights biotech strength as a large-cap innovator - AD HOC NEWS
Amgen (AMGN) Stock Dips While Market Gains: Key Facts - Yahoo Finance
2026 Best Places to Work in Kentucky rankings announced - pmg-ky1.com
The Dow Couldn't Keep Up With Chip Stocks on Monday - The Motley Fool
Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Amgen Slides as Tavneos Scrutiny and Pipeline Questions Weigh on Shares - Quiver Quantitative
AMGN Reiterated by Cantor Fitzgerald -- Price Target Maintained at $350 - GuruFocus
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 - Investing.com
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $350 By Investing.com - Investing.com Canada
Amgen Inc. $AMGN Shares Bought by Stephens Inc. AR - MarketBeat
Amgen Inc. (AMGN) Stock Analysis: Evaluating the 101% Return on Equity Amid a Diverse Portfolio - DirectorsTalk Interviews
Dividend Assets Capital LLC Sells 9,002 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. Stock 12‑Month Price Target Raised to $355.04, Implies 5% Downside - TradingView
Ascentis Independent Advisors Acquires 8,192 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Could Be 45% Below Fair Value As Court Blocks Enbrel Price Cap - simplywall.st
AMGNAMGEN Inc Latest SEC Filings - Finviz
Amgen Stock: What Happened After a Judge Blocks Colorado’s Enbrel Price Cap? - TIKR.com
Vivid Wealth Management LLC Invests $2.46 Million in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by QRG Capital Management Inc. - MarketBeat
Amgen Inc. $AMGN Shares Sold by Simplify Asset Management Inc. - MarketBeat
Boston Trust Walden Corp Purchases 12,647 Shares of Amgen Inc. $AMGN - MarketBeat
Y Intercept Hong Kong Ltd Takes $11.40 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Peregrine Asset Advisers Inc. - MarketBeat
Strs Ohio Cuts Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Fights to Keep Avacopan on Market Amid Rising Concerns - Medscape
Amgen Inc. $AMGN Position Boosted by Elevation Point Wealth Partners LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Acquires 62,190 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Is Up, What You Need To Know - Yahoo Finance
A Look at Amgen Inc (AMGN) After 3.5% Gain -- GF Value $353.58 v - GuruFocus
With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs - MedCity News
Amgen Inc Stock (AMGN) Moved Up by 3.01% on Jul 2: Key Drivers Unveiled - TradingKey
Does Tavneos Retraction And Possible Withdrawal Reshape The Bull Case For Amgen (AMGN)? - simplywall.st
Vertrix Wealth Management LLC Buys New Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Lessened by Fulton Bank N.A. - MarketBeat
Amgen Secures Court Halt to Colorado Board’s Price Cap on Enbrel - Bloomberg Law News
Amgen Wins Order Blocking Colorado's Enbrel Price Cap - Law360
Judge blocks Colorado’s first-of-its-kind price cap on Amgen’s Enbrel By Reuters - Investing.com
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel - Reuters
Controversial drug at center of multibillion-dollar Amgen deal faces more questions after paper retracted - The Business Journals
Amgen Inc. highlights its biotech pipeline as investors track long-term growth prospects - AD HOC NEWS
BMO Capital maintains Amgen stock rating citing Tavneos concerns - Investing.com
BMO Capital maintains Amgen stock rating citing Tavneos concerns By Investing.com - Investing.com Canada
Amgen or Biogen: Which Biotech Stock Appears Better Poised? - TradingView
BMO Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $400 - Moomoo
USS Investment Management Ltd Acquires 3,681 Shares of Amgen Inc. $AMGN - MarketBeat
Mizuho Highlights Amgen (AMGN) Pipeline Potential With MariTide and Olpasiran - Yahoo Finance
IFM Investors Pty Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat
InflaRx seeks to fill void left by Amgen’s Tavneos in Europe - European Biotechnology Magazine
Amgen (AMGN) Faces EU Push To Revoke Tavneos Approval - Yahoo Finance
Viridian may have edge over Amgen in eye drug showdown, analysts argue - BioPharma Dive
Amgen Faces Fresh Pressure After NEJM Retracts Trial Behind $459 Million Drug - GuruFocus
Medication used to treat heart failure recalled nationwide - The Hill
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - Yahoo Finance
Pathway Financial Advisers LLC Sells 5,382 Shares of Amgen Inc. $AMGN - MarketBeat
Forum Financial Management LP Sells 2,792 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals - Yahoo Finance
Heart and Kidney Medications Recalled Nationwide—Over 900,000 Bottles Affected - EatingWell
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings - Reuters
0.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):